Regular Article
Genetically Engineered GABA-Producing Cells Demonstrate Anticonvulsant Effects and Long-Term Transgene Expression When Transplanted into the Central Piriform Cortex of Rats

https://doi.org/10.1006/exnr.2002.7914Get rights and content

Abstract

Local application of GABA-potentiating agents can prevent or reduce the development and maintenance of behavioral seizures induced by limbic kindling in rats. Microinjection and lesion studies suggest that the transition zone between anterior and posterior piriform cortex (PC), termed here central PC, is a potential target for transplantation of GABA-producing cells. In the present study, we transplanted conditionally immortalized mouse cortical neurons, engineered with the GABA-synthesizing enzyme GAD65, to the central PC of rats. Suspensions of 1.5 × 105 cells in 1 μl were transplanted bilaterally. Control animals received transplantation of β-galactosidase (β-gal)-expressing cells. All rats were subsequently kindled through a chronically implanted electrode placed in the basolateral amygdala. The pre- and postkindling threshold currents for eliciting behavioral seizures were determined before and after kindling. We found the prekindling partial seizure threshold to be significantly increased by about 200% in the rats that received the GABA-producing cells compared to rats receiving β-gal-producing transplants. After kindling, the seizure threshold tended to be higher by 100% in rats that received GABA-producing cells, although the difference from controls was not statistically significant. GABA-producing transplants had no significant effect on the rate of amygdala kindling, but the latency to the first generalized seizure during kindling was significantly increased in animals receiving GABA-producing cells. The transplanted cells showed long-term GAD65 expression as verified immunohistologically after termination of the experiments. The findings substantiate and extend previous findings that the central PC is part of the anatomical substrate that facilitates propagation from partial to generalized seizures. The data demonstrate that genetically engineered cells have the potential to raise seizure thresholds when transplanted to the central PC.

References (43)

  • W.H. Oertel et al.

    Production of specific antiserum to rat brain glutamic acid decarboxylase by an injection of an antigen–antibody complex

    Neuroscience

    (1981)
  • R.J Racine

    Modification of seizure activity by electrical stimulation. II. Motor seizure

    Electroencephalogr. Clin. Neurophysiol.

    (1972)
  • K. Schwabe et al.

    Bilateral lesions of the central but not anterior or posterior parts of the piriform cortex retard amygdala kindling in rats

    Neuroscience

    (2000)
  • K. Thompson et al.

    Conditionally immortalized cell lines, engineered to produce and release GABA, modulate the development of behavioral seizures

    Exp. Neurol.

    (2000)
  • U. Wahnschaffe et al.

    The effects of lesions of the posterior piriform cortex on amygdala kindling in the rat

    Brain Res.

    (1993)
  • T Betts

    Using olfactory stimuli to abort or prevent seizures: Countermeasure or cue-controlled arousal manipulation? Is there something special about smell?

    Epilepsia

    (1995)
  • A. Björklund et al.

    Cell replacement therapies for central nervous system disorders

    Nat. Neurosci.

    (2000)
  • A. Bragin et al.

    Age-related loss of GABA-positive and GABA-negative neurons in neocortical transplants

    J. Neural Transplant. Plastic.

    (1993)
  • J. Carlsen et al.

    Tracing of two-neuron pathways in the olfactory system by the aid of transneuronal degeneration: Projections to the amygdaloid body and hippocampal formation

    J. Comp. Neurol.

    (1982)
  • U. Ebert et al.

    High susceptibility of the anterior and posterior piriform cortex to induction of convulsions by bicuculline

    Eur. J. Neurosci.

    (2000)
  • K. Gale et al.

    Identification of a discrete forebrain site responsible for the genesis of chemically induced seizures

  • Cited by (82)

    • Neuroprosthetics for controlling epilepsy

      2015, Implantable Neuroprostheses for Restoring Function
    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at the Department of Pharmacology, Toxicology, and Pharmacy, School of Veterinary Medicine Hannover, Bünteweg 17, D-30559 Hannover, Germany. Fax: (+49)511-953-8581. E-mail: [email protected].

    2

    Present address: Department of Veterans Affairs Medical Center West Los Angeles, Los Angeles, CA 90073.

    View full text